**Exhibit      31.1**

**CERTIFICATION**

**PURSUANT      TO      SECTION 302 OF**

**THE      SARBANES-OXLEY ACT OF 2002**

| 1. | I                have                reviewed this quarterly report on Form 10-QSB of Pathogenics,                Inc. |
|----|------------------------------------------------------------------------------------------------------------------------|

| 2. | Based                on my                knowledge, this report does not contain any untrue statement of material                fact or omit to state a material fact necessary to make the statements                made, in light of the circumstances under which such statements were                made,                not misleading with respect to the period covered by this                report; |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | Based                on my                knowledge, the financial statements, and other financial information                included in this report, fairly present in all material respects                the                financial condition, results of operations and cash flows of the                registrant as of, and for, the periods presented in this                report; |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | I                am                responsible for establishing and maintaining disclosure controls                and                procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for                the                registrant and have: |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | a) | designed                such                disclosure controls and procedures to ensure that material information                relating to the registrant, including its consolidated subsidiaries,                is                made known to us by others within those entities, particularly during                the                period in which this report is being                prepared; |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |   |   |
|--------|--------|--------|
|   | b) | evaluated                the                effectiveness of the registrant's disclosure controls and procedures                as of                a date within 90 days prior to the filing date of this report (the                "Evaluation Date"); and |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |   |   |
|--------|--------|--------|
|   | c) | presented                in                this report our conclusions about the effectiveness of the disclosure                controls and procedures based on our evaluation as of the Evaluation                Date; |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5. | I                have                disclosed, based on our most recent evaluation, to the registrant's                auditors and the audit committee of the registrant's board of directors                (or persons performing the equivalent                function): |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | a) | all                significant deficiencies in the design or operation of internal controls                which could adversely affect the registrant's ability to record,                process,                summarize and report financial data and have identified for the                registrant's auditors any material weaknesses in internal controls;                and |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |   |   |
|--------|--------|--------|
|   | b) | any                fraud,                whether or not material, that involves management or other employees                who                have a significant role in the registrant's internal controls;                and |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 6. | I                have                indicated in this report whether or not there were significant changes                in                internal controls or in other factors that could significantly affect                internal controls subsequent to the date of our most recent evaluation,                including any corrective actions with regard to significant deficiencies                and material weaknesses. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----